1. Articles in category: Other Business News

    1-24 of 805 1 2 3 4 ... 32 33 34 »

    1. Zeiss Meditec hits growth target

      Explore optics.org Other Business News
      Zeiss Meditec hits growth target

      Carl Zeiss Meditec says that despite ongoing market volatility it will continue to spend heavily on research and development activity, in a bid to ensure that it stays ahead in an increasingly competitive market. The Germany-headquartered company, which specializes in photonics-based healthcare technologies, made the comments as it posted a 5 per cent increase in annual revenues in its latest financial year. Sales of €906.4 million were near the upper end of the firm’s earlier predicted range, and improved margins delivered earnings before deductions for interest and tax of €133.9 million, up from €122.9 million last ...

      Read Full Article
      Mentions: Carl Zeiss Meditec Ludwin Monz

    2. Phoenix Research Labs Partners with Voxeleron to Advance Technology for Eye Research

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      Phoenix Research Labs Partners with Voxeleron to Advance Technology for Eye Research

      Phoenix Research Labs, Inc. today announced a partnership with Voxeleron, LLC to lead in the development of optical coherence tomography (OCT) segmentation software. The parties have entered into a strategic partnership to apply Voxeleron segmentation technology to the Phoenix Image-Guided Optical Coherence Tomography (OCT) data. This will allow users to readily analyze retinal layers, precisely measuring changes to thickness and structure over time. “We’re very excited by the opportunity to work with Phoenix. Clearly they have a strong portfolio of technologies optimized for animal eye research, so the addition of image analysis software can only strengthen their customers’ ability ...

      Read Full Article
      Mentions: Jonathan D. Oakley Phoenix Research Laboratories Voxeleron

    3. Carl Zeiss Meditec AG: Carl Zeiss Meditec looks back on a successful financial year

      Explore Aktien Other Business News
      Carl Zeiss Meditec AG: Carl Zeiss Meditec looks back on a successful financial year

      Medical technology company Carl Zeiss Meditec AG met its targets in financial year 2012/2013 with revenue growth of 5.2 percent to EUR 906.4 million and an increase in its EBIT margin of 0.5 percent to 14.8 percent. The Company continued to grow in all its strategic business units and regions. Earnings before interest and tax (EBIT) climbed to EUR 133.9 million (previous year: EUR 122.9 million); boosted further by a good financial result, earnings per share rose to EUR 1.15 (previous year: EUR 0.88). After particularly positive results in the fourth ...

      Read Full Article
      Mentions: Carl Zeiss Meditec Bausch & Lomb Ludwin Monz

    5. Wasatch Photonics launches 1300nm OCT system

      Explore optics.org Other Business News
      Wasatch Photonics launches 1300nm OCT system

      A new system from optical imaging company Wasatch Photonics could provide greater contrast and deeper sub-surface imaging than competitive techniques, the developer claims. The system could be used in the fields of material inspection and medical diagnosis, including cardiovascular and dermatological research, leading to faster and more accurate analyses. Wasatch Photonics, based in Logan, UT, USA, has developed a spectral-domain optical coherence tomography system in the 1300 nm wavelength range. The Utah-headquartered firm also has locations in Research Triangle Park in North Carolina and Purdue Research Park.

      Read Full Article
      Mentions: Wasatch Photonics

    6. Wasatch Photonics takes Spectral Domain OCT to 1300 nm

      Explore Optical Coherence Tomography News Other Business News
      Wasatch Photonics takes Spectral Domain OCT to 1300 nm

      Wasatch Photonics Inc. announced the launch of a new spectral domain optical coherence tomography (OCT) system in the wavelength range of 1300-nm. The North Carolina-based systems division of the company adds to its repertoire of 800-nm OCT systems and OCT spectrometers. The 1300-nm OCT to date is dominated by systems using swept-source lasers. With this launch, Wasatch Photonics hopes to bring the stability and simplicity of 800-nm spectral domain systems to the 1300-nm range. The optimized spectrometer allows the long imaging range using 2048 pixel spectrometer at speeds of up to 70,000 lines/sec. “The new OCT system in ...

      Read Full Article
      Mentions: Massachusetts Institute of Technology Wasatch Photonics

    7. Optovue Launches Next Generation Widefield Enface OCT

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      Optovue Launches Next Generation Widefield Enface OCT

      Optovue ( www.optovue.com ), a pioneer in spectral-domain optical coherence tomography (SD-OCT), today announced the worldwide launch and availability of Avanti Widefield Enface OCT. Avanti will make its US debut at the annual American Academy of Ophthalmology (AAO) meeting, November 16-19 in New Orleans. Avanti is a next generation diagnostic device providing an all-in-one solution for posterior and anterior high-speed, high-resolution OCT imaging offering 70,000 A-scans per second, Widefield 3D motion correction and 3 micron digital resolution (sampling). With the next wave of OCT technology innovation in mind, Avanti is designed as a scalable platform to take eye care ...

      Read Full Article
      Mentions: Optovue Jay Wei FDA

    8. Heidelberg Engineering appoints General Manager of US Operations

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      Heidelberg Engineering appoints General Manager of US Operations

      Heidelberg Engineering has appointed Lance Patton as General Manager of its US operations. Mr. Patton joined Heidelberg Engineering Inc. as a Western Regional Sales Manager in 2007 and currently serves as VP of Sales and Marketing. “Lance played an important role in building a first in class sales team known for its exceptional competencies in clinical and commercial aspects of diagnostic imaging” said Dr. Kester Nahen, Managing Director of Heidelberg Engineering GmbH. “I am excited about this appointment and look forward to drive continued growth of the US business in the years to come”, said Mr. Patton. About Heidelberg Engineering ...

      Read Full Article
      Mentions: Heidelberg Engineering Kester Nahen

    9. Quite a Contrast: Volcano Corporation May Cancel its Intravascular OCT Product and St. Jude Medical Indicates $1B a Year Revenue Opportunity

      Explore Optical Coherence Tomography News Cardiology , Other Business News
      Quite a Contrast: Volcano Corporation May Cancel its Intravascular OCT Product and St. Jude Medical Indicates $1B a Year Revenue Opportunity

      Earlier this week it seemed Volcano Corporation Indicated it would cancel its intravascular OCT development program for a variety of reasons. The CEO made the statement “ We believe this reprioritization initiative better focuses and positions Volcano to compete more effectively in our growth markets”. See Article . Less than one week later a write from Minnesota Public Radio seemed to indicate that St. Jude’s intravascular OCT program was going well and that “ The company expects doctors will quickly embrace the procedure as they learn about it and the technology could generate $1 billion in sales each year, although industry analyst ...

      Read Full Article
      Mentions: Volcano Corporation St. Jude Medical

    10. Carl Zeiss faces New Competition from Haag-Streit, Nidek and Topcon in the $600 Million Diagnostic Ophthalmic Device Market, reports iData Research

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      Carl Zeiss faces New Competition from Haag-Streit, Nidek and Topcon in the $600 Million Diagnostic Ophthalmic Device Market, reports iData Research

      iData Research, the leading global authority in medical device and pharmaceutical market research, has recently published a report for the U.S. diagnostic ophthalmic device markets. The report estimates a combined market value of $597 million and growing; expected to reach nearly $800 million by 2020. These markets include optical coherence tomographers (OCTs), fundus cameras, slit lamps, perimeters, tonometers, autorefractors and keratometers, binocular indirect ophthalmoscopes, ophthalmic ultrasound systems, wavefront aberrometers, corneal topographers and optical biometers. Fast-Growing Market: OCT Optical coherence tomography (OCT) is experiencing double-digit growth due to strong sales of combination OCT devices such as OCT with built-in fundus ...

      Read Full Article
      Mentions: Nidek Topcon Medical Systems Carl Zeiss Meditec

    11. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast

      Explore Volcano Corporation Cardiology , Other Business News
      Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast

      Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Canaccord Genuity 2013 Medical Technology & Diagnostics Forum on Thursday, November 14. The presentation by John Dahldorf, chief financial officer, will begin at 10:30 a.m., Eastern Standard Time (7:30 a.m., Pacific Standard Time). The presentation will be available through http://wsw.com/webcast/canaccord12/ and via the company's website at www.volcanocorp.com . Volcano Corporation is revolutionizing the medical device ...

      Read Full Article
      Mentions: Volcano Corporation John Dahldorf

    12. Will This Medical Device Maker (Volcano) Keep Sliding?

      Explore Fool.com Cardiology , Other Business News
      Will This Medical Device Maker (Volcano) Keep Sliding?

      Shares of Volcano imploded at the end of October after the medical device maker reported a weaker-than-expected third quarter. The stock is now down more than 18% over the past month, and has underperformed its larger industry peers -- Boston Scientific , St. Jude Medical , and Medtronic -- by a wide margin over the past year. Source: YCharts. Will shares of Volcano continue to tumble, or is further downside limited at today's price? A disappointing third quarter For its third quarter, Volcano reported a non-GAAP loss of $0.08 per share, down sharply from a profit of $0.04 that it reported ...

      Read Full Article
      Mentions: Boston Scientific St. Jude Medical

    13. Funding Dries Up for Medical Startups; Companies Are Squeezed by Venture-Capital Drought

      Explore Business News & Financial News Funding , Other Business News
      Funding Dries Up for Medical Startups; Companies Are Squeezed by Venture-Capital Drought

      The medical-device industry, struggling to adapt to a thriftier health-care system, is getting squeezed by a venture-capital drought. Investment in the medical-device and equipment industry is on pace to fall to $2.14 billion this year, down more than 40% from 2007 and the sharpest drop among the top five industry recipients of venture funding, according to an analysis of data compiled by PricewaterhouseCoopers and the National Venture Capital Association. Venture money received by the biotechnology sector declined 28% over the same period, while software startups recorded a 75% increase. Firms like SetPoint Medical, a developer of a nerve-stimulation device ...

      Read Full Article
      Mentions: Boston Scientific St. Jude Medical

    14. Wasatch Photonics hires director of product management and marketing

      Explore Purdue Research Park Other Business News
      Wasatch Photonics hires director of product management and marketing

      Nishant Mohan, Ph.D., has joined Wasatch Photonics Inc. as its director of product management and marketing. Mohan will develop and commercialize the next generation of the company's optical coherence tomography spectrometers and systems. He previously had been in research and development at Bausch + Lomb in Rochester, N.Y. Mike Sullivan, general manager of Wasatch Photonics, said Mohan has more than a decade of experience with optical coherence tomography. "Nishant played a pioneering role in employing the technology for novel applications ranging from blood flow estimation to contact lens imaging. His experience in academia and industry gives him an ...

      Read Full Article
      Mentions: Wasatch Photonics

    15. Volcano Corporation (VOLC): Investor Activism Erupts At Volcano

      Explore seekingalpha.com Cardiology , Other Business News
      Volcano Corporation (VOLC): Investor Activism Erupts At Volcano

      While shareholder activism is a fact of life in the pharma sphere, it is less common in medtech. But this could be changing. The worrying downturn in medtech M&A over the past year means that some investors are getting restless as an exit is denied them, and more and more may take it upon themselves to ensure companies make appealing takeover targets. Volcano Corp. ( VOLC ), a cardiovascular imaging device developer, might be the bellwether. The investment fund Engaged Capital, which has a 5.1% stake in Volcano, is trying to steer the company towards a $200m share buyback and ...

      Read Full Article
      Mentions: Volcano Corporation

    16. Rising Incidence of Peripheral and Coronary Artery Diseases to Drive Demand for IVUS Imaging, According to New Report by Global Industry Analysts, Inc.

      Explore prweb.com Cardiology , Other Business News
      Rising Incidence of Peripheral and Coronary Artery Diseases to Drive Demand for IVUS Imaging, According to New Report by Global Industry Analysts, Inc.

      GIA announces the release of a comprehensive global report on Intravascular Ultrasound (IVUS) markets. Global market for Intravascular Ultrasound (IVUS) is forecast to reach US$695.7 million by 2018, driven by rising incidence of peripheral and coronary artery diseases aggravated by poor lifestyle habits and increasing prevalence of co-morbid conditions including diabetes and obesity.

      Read Full Article
      Mentions: Terumo Corporation Volcano Corporation Boston Scientific

    17. Volcano Corporation Cancels its Intravascular OCT Development Program?

      Explore Optical Coherence Tomography News Cardiology , Other Business News
      Volcano Corporation Cancels its Intravascular OCT Development Program?

      Volcano corporation recently reported on its third quarter results and announced a strategic reprioritization initiative which among other things stated that it was discontinuation development of its Optical Coherence Tomography intravascular imaging product. The report can be seen HERE . It is unclear why Volcano took this position on OCT specially since it saved a small amount of near term R&D dollars and there is a big potential market that threatens the IVUS market (a Volcano strength). But lots of potential factors could be at play including a recent big drop it is stock value (see Link ) due to investor ...

      Read Full Article
      Mentions: Terumo Corporation Scott Huennekens Volcano Corporation

    18. Volcano Reports Third Quarter Results

      Explore Volcano Corporation Cardiology , Other Business News
      Volcano Reports Third Quarter Results

      Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today reported results for the third quarter and first nine months of 2013. The company also today announced a strategic reprioritization and reallocation of resources within its distribution, research and development and clinical programs to focus on areas of strong projected growth in FFR (Fractional Flow Reserve), peripheral applications, coronary IVUS (Intravascular Imaging) driven by the ADAPT-DES clinical data and Axsun Medical. This has resulted in a corporate restructuring charge that reflects the ...

      Read Full Article
      Mentions: Scott Huennekens Volcano Corporation

    19. Bioptigen now shipping Envisu XHR Extreme Resolution OCT Imaging systems

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      Bioptigen now shipping Envisu XHR Extreme Resolution OCT Imaging systems

      Bioptigen (www.bioptigen.com) announces today it has begun shipping the Envisu TM S4100 XHR spectral domain optical coherence tomography research system capable of producing volumetric images with unmatched 1 um axial resolution. The system is the only OCT system in the world capable of acquiring images with 1.5 um x 1.5 um x 1 um voxel size. Additionally, this resolution is delivered in full volumes up to 1000 x 1000 x 1000 pixels, designed so that researchers do not miss the earliest signatures of pathology. Bioptigen achieves this capability with a focus on precision optical design, proprietary ...

      Read Full Article
      Mentions: Bioptigen NKT Photonics Bioptigen Envisu R4300

    20. Cardiovascular Device Markets Reach Billions

      Explore TMD – Today’s Medical Developments Cardiology , Other Business News
      Cardiovascular Device Markets Reach Billions

      iData Research , the leading global authority in medical device and pharmaceutical market research, has published a new report series for the U.S. Cardiology Device Markets. Cardiovascular disease is much more prevalent among patients over 55 years of age; therefore as the U.S. population ages, the incidence of cardiovascular disease will increase. In addition, rising rates of obesity will also contribute to the incidence of heart disease. As the baby boomer generation in the U.S. ages, the patient population will increase. This increase in the patient population will lead to an annual 3% to 4% increase in the ...

      Read Full Article
      Mentions: Boston Scientific FDA St. Jude Medical

    21. Volcano Announces New Two-Year Results of Largest Prospective Study of Use of IVUS in Stent Placement

      Explore Volcano Corporation Cardiology , Other Business News
      Volcano Announces New Two-Year Results of Largest Prospective Study of Use of IVUS in Stent Placement

      Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced new two-year outcomes from an analysis of use of intravascular ultrasound (IVUS) in the ADAPT-DES ( A ssessment of D ual A nti P latelet T herapy with D rug- E luting S tents) Study, the largest prospective registry of IVUS use to date. Results suggest that, in the ADAPT-DES study, use of IVUS with angiography (compared with angiography alone) in placing the current generation of drug-eluting stents (DES) was associated with reductions ...

      Read Full Article
      Mentions: Cardiovascular Research Foundation

    22. Volcano Corporation Announces Third Quarter 2013 Revenues, Updated Revenue Guidance For Full Year 2013 And Preliminary Revenue Guidance For 2014

      Explore Volcano Corporation Cardiology , Other Business News
      Volcano Corporation Announces Third Quarter 2013 Revenues, Updated Revenue Guidance For Full Year 2013 And Preliminary Revenue Guidance For 2014

      Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it expects revenues for the third quarter of 2013 on a reported basis will be approximately $95.8 million. This compares with revenues on a reported basis of $93.7 million in the same period a year ago. The company said that FX exchange rates had a negative impact of approximately $5.4 million compared to the third quarter a year ago. Medical segment revenues increased approximately three percent and ...

      Read Full Article
      Mentions: Scott Huennekens Volcano Corporation

    23. 3-D St. Jude Medical launches technology that gives docs real-time, 360-degree

      Explore MedCity News Cardiology , Other Business News
      3-D St. Jude Medical launches technology that gives docs real-time, 360-degree

      St. Jude Medical (STJ) announced FDA approval of its ILUMIEN OPTIS PCI Optimization System , and the product’s U.S. launch. The device gives physicians a real-time, 360-degree panoramic view of the arteries, to help with stent placement and to guide treatment for patients with coronary artery disease. But what’s the true value proposition between this new iteration and the last? Perhaps potential for reduced hospital readmissions. In the company’s FAME 2 study, “hospital readmission because of an urgent revascularization (was) reduced by 86 percent” when the company’s PressureWire technology was used, according to a company statement .

      Read Full Article
      Mentions: FDA St. Jude Medical

    24. New 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement Launches in the US

      Explore Stock Quote Cardiology , Other Business News
      New 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement Launches in the US

      St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval and launch of its ILUMIEN ™ OPTIS ™ PCI Optimization ™ System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease (CAD). The system will be on display for the first time in the U.S. during the 2013 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The ILUMIEN platform helps physicians better understand which arteries should be treated and how best to treat them. It works by integrating both Fractional Flow Reserve ...

      Read Full Article
      Mentions: Cardiovascular Research Foundation FDA St. Jude Medical
    1-24 of 805 1 2 3 4 ... 32 33 34 »
  1. Search:

  2. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology

    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents

    3. Technology:

      Broadband Sources, Doppler, Probes, Tunable Sources

    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks

  4. Popular Articles

  5. Organizations in the News

    1. (2 articles) FDA
    2. (1 articles) Massachusetts Institute of Technology

  6. People in the News

    1. (2 articles) Ludwin Monz
    2. (1 articles) John Dahldorf
    3. (1 articles) Jay Wei
    4. (1 articles) Kester Nahen
    5. (1 articles) Jonathan D. Oakley
    6. (1 articles) Jon Holmes

  7. OCT Companies in the News

    1. (4 articles) Volcano Corporation
    2. (3 articles) Wasatch Photonics
    3. (3 articles) Carl Zeiss Meditec
    4. (3 articles) Boston Scientific
    5. (3 articles) St. Jude Medical
    6. (1 articles) Optovue
    7. (1 articles) Voxeleron
    8. (1 articles) Heidelberg Engineering
    9. (1 articles) Topcon Medical Systems
    10. (1 articles) Phoenix Research Laboratories
    11. (1 articles) Michelson Diagnostics
    12. (1 articles) Nidek

  8. OCT Products in the News

    1. (1 articles) Optovue RTVue-100
    2. (1 articles) Optovue iVue
    3. (1 articles) Michelson Diagnostics Vivosight